Study confirms relevance of SVR endpoint for patients receiving HCV treatment

SVR, which has been challenged in regard to its association with clinical outcomes, has been confirmed as a prognosis-altering endpoint in patients with hepatitis C virus, according to findings published in Clinical Infectious Diseases.As a result, SVR can serve as a surrogate endpoint that results in better clinical outcomes, according to the study results.“Despite a lot of data showing the benefits of SVR in terms of both liver and non-liver-related outcomes, some have still argued that SVR is not a clinically important endpoint. They have made the case that, although studies haveRead More

Share on facebook
Share on twitter
Share on linkedin